These results indicate that CCL2 enhances EPSCs via CCR2 and glutamate receptors leading to neuronal injury.Taken together, our data suggest a potential role for CCL2 in the pathogenesis of HIVE/HAD and perhaps other neurodegenerative disorders by which immune and inflammatory mediators are involved in the disease progression.